Caraway distillate ameliorate hyperlipidemia and hepatic steatosis in obese rat (Record no. 16972)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | a |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20220629155621.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 220629b xxu||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | AIKTC-KRRC |
| Transcribing agency | AIKTC-KRRC |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 16912 |
| Author | Haque, Md Rafiul |
| 245 ## - TITLE STATEMENT | |
| Title | Caraway distillate ameliorate hyperlipidemia and hepatic steatosis in obese rat |
| 250 ## - EDITION STATEMENT | |
| Volume, Issue number | Vol.15(4), Oct-Dec |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | M P |
| Name of publisher, distributor, etc. | BRNSS Publication Hub. |
| Year | 2021 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Pagination | 406-412p. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Background: Carum carvi L. (family; Apiaceae, common name; caraway) is conventionally used for the treatment of flatulence, dyspepsia, fatness, asthma, and amenorrhea in Unani as well as the Ayurvedic System of Indian Medicine. Aim and Objective: The present study was planned to scrutinize the effect of caraway distillate (CD) on hyperlipidemia and hepatic steatosis in a rat model of high-fat diet (HFD)-induced obesity. Materials and Methods: HFD-fed rats were administered with CD (7.75 ml/kg body weight [BW] twice a day, orally) and CD1 (7.75 ml/kg BW once a day, orally) for 4 weeks. Results: After termination of the study, CD and CD1 treatments showed significant (P < 0.001) attenuation in cholesterol, triglycerides, low-density lipoprotein cholesterol, leptin levels, and pancreatic lipase activity and significant (P < 0.001) boost in highdensity lipoprotein cholesterol. Furthermore, CD and CD1 treatment also noticeably attenuated the extent of hepatic steatosis. Conclusions: These results suggest that CD has a strong protective effect against hyperlipidemia and hepatic steatosis in HFD-induced obesity on a rat model. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| 9 (RLIN) | 4755 |
| Topical term or geographic name entry element | PHARMACOGNOSY |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 16230 |
| Co-Author | Rana, Kavita |
| 773 0# - HOST ITEM ENTRY | |
| Place, publisher, and date of publication | Mandsaur B.R. Nahata Smriti Sansthan |
| Title | International journal of green pharmacy |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| URL | https://www.greenpharmacy.info/index.php/ijgp/article/view/3192 |
| Link text | Click here |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | |
| Koha item type | Articles Abstract Database |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Permanent Location | Current Location | Shelving location | Date acquired | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| School of Pharmacy | School of Pharmacy | Archieval Section | 2022-06-29 | 2022-0969 | 2022-06-29 | 2022-06-29 | Articles Abstract Database |